Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-000096

Chief Executive Officer gave up 2,209 shares (to pay taxes)

  • Chief Executive Officer acquired 4,895 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-31 Exercise or conversion : show line 1 in the form +4,895 61,057 D
2024-12-31 Shares withheld for taxes : show line 2 in the form −2,209 $22.00 $48,598 58,848 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-31 Exercise or conversion : show line 3 in the form Restricted Stock Units −4,895 24,879 D
Loading xslF345X05/rdgdoc.xml…